Limhamn, Sweden

Rikard Bryland

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 10.0

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rikard Bryland

Introduction: Rikard Bryland, an accomplished inventor based in Limhamn, Sweden, has made significant strides in the pharmaceutical field. With a total of five patents to his name, Bryland is recognized for his pioneering work that focuses on the development of formulations and modifications for the drug odevixibat.

Latest Patents: Bryland’s latest patents include groundbreaking advancements in the crystal modifications of odevixibat. Specifically, he has developed crystal modifications 1 and 2, which offer new solutions in the treatment of various medical conditions. In addition, he has also invented a pharmaceutical formulation of odevixibat that consists of small particles, designed particularly for pediatric use. This formulation aims to tackle liver diseases such as bile acid-dependent liver diseases, including cholestatic liver diseases like biliary atresia, progressive familial intrahepatic cholestasis (PFIC), and Alagille syndrome (ALGS).

Career Highlights: Currently, Rikard Bryland works at Albireo AB, where he continues his research and development efforts in the pharmaceutical industry. His contributions have been pivotal in advancing treatment options for patients with complex liver diseases. His expertise and innovative mindset have positioned him as a key player in pharmaceutical research.

Collaborations: Throughout his career, Bryland has collaborated with talented colleagues, including Robert Lundqvist and Ingvar Ymen. These partnerships have been instrumental in fostering a creative environment that promotes the innovation needed to tackle challenging medical issues.

Conclusion: Rikard Bryland's journey as an inventor exemplifies the impact of dedicated research and innovation in the pharmaceutical sector. His work, particularly concerning odevixibat, continues to offer hope for many patients suffering from liver conditions, showcasing the importance of continuous efforts in medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…